ADC Therapeutics ADCT reported its Q1 earnings results on Monday, May 9, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
ADC Therapeutics beat estimated earnings by 48.57%, reporting an EPS of $-0.36 versus an estimate of $-0.7.
Revenue was up $46.50 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.47 which was followed by a 4.67% drop in the share price the next day.
Here's a look at ADC Therapeutics's past performance:
Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
---|---|---|---|---|
EPS Estimate | -0.86 | -0.92 | -0.82 | -0.90 |
EPS Actual | -0.39 | -0.59 | -0.70 | -0.74 |
Revenue Estimate | 16.46M | 7.39M | 2.37M | 90.00K |
Revenue Actual | 17.01M | 13.15M | 3.76M | 0 |
To track all earnings releases for ADC Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.